Rep. Claudia Tenney

Maddy summaryHR 1492 amends the Social Security Act to extend the negotiation period for standard drug manufacturers under the federal drug pricing program. Specifically, it changes the timeframe from 7 years to 11 years for small-molecule drugs (like traditional pills) to negotiate prices with the government, aligning it with the existing 12-year period for complex biologic drugs (like insulin or monoclonal antibodies). This adjustment directly affects pharmaceutical companies that produce small-molecule drugs, giving them a longer window to negotiate pricing terms. The bill makes this change effective as if it had been part of the 2022 law that established the program.

Maddy summaryHR 1490, the TRIO Access Act, allows colleges to use tax return information from FAFSA applications for specific federal student support programs. It amends tax law (Internal Revenue Code §6103) and the Higher Education Act to permit institutions to share this data with students applying for TRIO programs like Student Support Services (Section 402D) and the McNair Post-Baccalaureate Program (Section 402E). The bill clarifies that tax information collected for financial aid may also be used to determine eligibility for these TRIO programs. This change directly affects colleges and students seeking support through these specific federal initiatives.

Maddy summaryHR 534, the CONTAINER Act, allows Border States (adjacent to the U.S. northern or southern borders) to place temporary barriers on federal land without needing a special use permit, provided they notify the relevant federal agency 45 days in advance. The bill directly affects Border States and federal land management agencies (like the Bureau of Land Management and National Park Service) by streamlining the process for deploying short-term border security structures. Key provisions include a one-year initial placement period for these barriers, with potential 90-day extensions if U.S. Customs and Border Protection determines operational control hasn't been achieved. This eliminates a bureaucratic hurdle for states seeking rapid border security measures.

Maddy summaryThis bill establishes a Veterans Affairs grant program to fund peer-to-peer mental health support for veterans. It provides up to $250,000 per grant to eligible organizations (like veteran nonprofits, service groups, or state agencies) to hire veterans as peer specialists who host nonclinical support groups and offer 24/7 mental health assistance. The program prohibits grant recipients from collecting or reporting veterans' personal information. It directly affects veterans seeking accessible, nonclinical mental health support through peer-led services.

Maddy summaryHR 1421, the "Make American Flags in America Act of 2025," requires all flags of the United States displayed on federal property or procured by federal agencies to be 100% manufactured in the United States. This directly affects federal agencies (including executive departments, military branches, and legislative/judicial offices) by banning the use of foreign-made flags for official displays or purchases. The bill sets a 90-day deadline for procurement changes and a two-year timeline for display requirements, while excluding private entities from these rules. It also mandates a Federal Trade Commission study on enforcing country-of-origin labeling for flags, with a report due within one year of enactment.

Maddy summaryHR 1414, titled "Cameron’s Law," increases the tax credit for pharmaceutical companies developing orphan drugs (medicines for rare diseases) from 25% to 50% of qualified research expenses. This change directly affects drug manufacturers investing in treatments for conditions affecting fewer than 200,000 people in the U.S. The bill amends the Internal Revenue Code to implement this higher credit rate, effective for taxable years starting after the law’s enactment. It provides a concrete financial incentive to encourage research into rare disease treatments without altering eligibility criteria or adding new requirements.

Maddy summaryHR 1410 expands access to mental health care for 9/11 responders and survivors by allowing licensed mental health providers (not just physicians) to conduct initial health evaluations and certifications under the World Trade Center Health Program. It adjusts the program’s funding formula to account for changing enrollment numbers by linking annual funding to the previous year’s enrollment ratio, and clarifies that deceased individuals are excluded from enrollment counts. The bill also extends the timeframe for adding new health conditions to the program’s list and requires a 2028 report assessing long-term funding needs through 2090. These changes aim to streamline eligibility, improve care access, and ensure sustainable funding for the program.

Maddy summaryThis resolution urges the UK, France, and Germany (the E3) to trigger the UN Security Council's "snapback" mechanism under Resolution 2231 to reimpose nuclear-related sanctions on Iran before the mechanism expires on October 18, 2025. It cites Iran's violations of the 2015 nuclear deal (JCPOA), including enriching uranium to 60% purity, expanding nuclear facilities, and blocking IAEA inspections. The E3 would need to formally request the UN Security Council to restore sanctions lifted under the JCPOA. The resolution does not impose sanctions itself but calls for diplomatic action to prevent Iran from advancing its nuclear program.

Maddy summaryThe PILLS Act creates tax credits to encourage domestic production of generic drugs and biosimilars in the United States. It offers a production credit of 30% (increasing to 35% for final drug production) with an additional bonus for components made with U.S. materials, phasing out after 2033. The bill also provides a separate 25% investment credit for facilities building or expanding production of these drugs, ending for construction after December 31, 2028. To qualify, manufacturers must produce drugs in the U.S., meet FDA compliance requirements, and not be foreign entities of concern. These provisions primarily affect U.S.-based pharmaceutical companies producing generic drugs and biosimilars.

Maddy summaryHR 1395, titled "Trump’s Birthday and Flag Day Holiday Establishment Act," proposes adding "Trump’s Birthday and Flag Day" as a federal holiday on June 14 under Section 6103(a) of Title 5, U.S. Code. This would directly affect federal employees and agencies by designating June 14 as a paid holiday, replacing the existing Flag Day observance. The bill’s key provision amends the federal holiday schedule to combine the current Flag Day (June 14) with a new holiday honoring Donald Trump’s birthday on the same date. It does not change the date of Flag Day but merges it with the proposed Trump birthday observance. The bill is procedural, focusing solely on naming the holiday, not altering its date or scope.